[Efficacy and safety of a new antiplatelet agent - vorapaxar: TRA2P-TIMI 50]
- PMID: 23080105
[Efficacy and safety of a new antiplatelet agent - vorapaxar: TRA2P-TIMI 50]
Comment on
-
Vorapaxar in the secondary prevention of atherothrombotic events.N Engl J Med. 2012 Apr 12;366(15):1404-13. doi: 10.1056/NEJMoa1200933. Epub 2012 Mar 24. N Engl J Med. 2012. PMID: 22443427 Clinical Trial.